1Dahlof B,Peter S, Neil R,et al. For the ASCOT investingatots. Prevention of cadiovascular events an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumetiazide as required, in the Anglo - Scandinavian Cadiac Outcomes Trial - Blood Pressure Lowering Arm( ASCOT - BPLA) : a muhicentre randomized controlled trial[J]. Lancet,2005,366(9490) :895 - 906
2National Institute of Clinical Excellence(NICE). Hypertension:management of hypertension in adults in primary care ( partia update) [S]. 2006: 45
3Williams B. Recent hypertension trials. Implication and controversies[J]. J Am Coll Cadiol,2005,45(6) :813 - 827
4The CAFE Investigators, for the Anglo - Scandinavian Cardiac Outcomes Trial (ASCOT) Investigators, CAFE Steering Committee and Writing Committee. Differential impact of blood pressure - lowering drugs on central aortic Pressure and clinical outcomes: principal results of the conduit artery function evaluation (CAFE) study[J]. Circulation, 2006.113 (3) : 1213 - 1225
5Pannier BM, Guerin AP, Marchais SJ. et al. Different aortic reflection wave responses following long-term angiotensin - conwerting enzyme inhibition and beta - blocker in essential hypertension [J]. Clin Exp Physiol, 2001,28 (5) : 1074 - 1077
6Kelly RP, Millasseau SC. Ritter JM, et al. Vasoactive drugs influence aortic augmentation index independently of pulse wave velocity in healthy rrien[J]. Hypertension.2001,37(6) :1429 - 1433
7Hirata K. Viachopoulos C. Adji A, et al. Benefits from angiotensin-converting enzyme inhibitor (beyond blood pressure lowering)) : beyond blood pressure or beyond the brachial artery? [J]. J Hypertens,2005,23(4) :903 - 904
8Deary AJ, Schumann AL, Murfet H, et al. Influence of drugs and gender on the arterial pulse wave and natriuretic peptlde secretion in untreated patients with essential hypertension [J]. Clin Sci,2002,103(3) :493- 499
9AramV,Chobanian MD. Isolated systdic hypertension in the elderly[J]. N Engl J Med,2007,357(23):789- 796
10Asmar R,Topouchian J. Pannian B, et al. Pulse wave velocity as endpoint in large- scale intervention trial. The COMPLIOR study[J]. J Hypertens,2001,19(40) :813 - 818
